Ra Medical Systems

General Information


We are a commercial-stage medical device company leveraging our advanced excimer laser-based platform for use in the treatment of vascular and dermatological diseases. We believe our products enhance patients’ quality of life by restoring blood-flow in arteries and clearing chronic skin conditions. In June 2018, we completed our 12 month commercial launch period, which included training, production, and staffing for the marketing of the DABRA laser system and disposable catheter, together referred to as DABRA, in the United States.

Employees: 75
Founded: 2002
Contact Information
Address 2070 Las Palmas Drive, Carlsbad, CA 92011, US
Phone Number (760) 804-1648
Web Address http://www.ramed.com
View Prospectus: Ra Medical Systems
Financial Information
Market Cap $205.8mil
Revenues $5.4 mil (last 12 months)
Net Income $-15.9 mil (last 12 months)
IPO Profile
Symbol RMED
Exchange NYSE
Shares (millions): 3.9
Price range $17.00 - $17.00
Est. $ Volume $66.3 mil
Manager / Joint Managers Piper Jaffray/ Cantor
CO-Managers SunTrust Robinson Humphrey/ Nomura/ Maxim Group
Expected To Trade: 9/27/2018
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change